Positional Isomers of Monopegylated Interferon α-2a: Isolation, Characterization, and Biological Activity
Seth P. Monkarsh,Yuemei Ma,Anthony Aglione,Pascal Bailon,Doreen Ciolek,Barabara Debarbieri,Mary C. Graves,Kurt Hollfelder,Hanspeter Michel,Alicia Palleroni,Jill E. Porter,Emil Russoman,Swapan Roy,Yu-Ching E. Pan;Seth P. Monkarsh;Yuemei Ma;Anthony Aglione;Pascal Bailon;Doreen Ciolek;Barabara Debarbieri;Mary C. Graves;Kurt Hollfelder;Hanspeter Michel;Alicia Palleroni;Jill E. Porter;Emil Russoman;Swapan Roy;Yu-Ching E. Pan;
analytical biochemistry1997Vol. 247pp. 434-440
160
pan1997analyticalpositional
Abstract
The success of recombinant interferon alpha in the clinic in part is limited by two properties of the protein: short serum half-life and immunogenicity. To improve these properties, interferon alpha-2a was conjugated with polyethylene glycol (PEG-5000). A homogeneous preparation of monopegylated interferon alpha-2a was subjected to vigorous analytical and activity characterization. A newly developed ampholyte-free chromatofocussing-like cation-exchange HPLC method utilizing a sulfopropyl resin was used to separate the monopegylated protein into 11 species. Peptide mapping, sequencing, and mass spectrometric analyses indicated that these species are positional isomers where each isomer represents a single polymer molecule conjugated to one specific lysine residue. No species with a modification at the amino terminus was observed. All 11 isomers show antiviral and antiproliferative activities in the same range as the parent monopegylated interferon alpha-2a.